BULLFROG AI HOLDINGS, INC. Increase (Decrease) in Prepaid Expense
BULLFROG AI HOLDINGS, INC. (BFRG) reported Increase (Decrease) in Prepaid Expense of $117.24 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2025-08-13
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-06-30 was -$51.29K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-03-31 was $168.53K, a 65.37% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-12-31 was -$246.94K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-09-30 was -$98.82K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2024 was -$34.28K, a 126.20% decline from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2023 was $130.88K, a 772.55% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2022 was $15.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$51.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $117.24K 10-Q · filed 2025-08-13 | -$129.70K derived: sum of 3 quarters · filed 2025-08-13 | -$228.52K derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $168.53K 10-Q · filed 2025-05-13 | -$78.41K derived: sum of 2 quarters · filed 2025-05-13 | -$177.23K derived: sum of 3 quarters · filed 2025-05-13 | -$352.47K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-12-31 | -$246.94K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$345.76K derived: sum of 2 quarters · filed 2025-03-14 | -$521.00K derived: sum of 3 quarters · filed 2025-08-13 | -$34.28K 10-K · filed 2025-03-14 |
| 2024-09-30 | -$98.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$274.06K derived: sum of 2 quarters · filed 2025-08-13 | $212.66K 10-Q · filed 2024-11-08 | $6.10K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-06-30 | -$175.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $311.47K 10-Q · filed 2025-08-13 | $104.92K derived: sum of 3 quarters · filed 2025-08-13 | -$118.25K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $486.71K 10-Q · filed 2025-05-13 | $280.16K derived: sum of 2 quarters · filed 2025-05-13 | $56.99K derived: sum of 3 quarters · filed 2025-05-13 | -$173.70K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$206.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$429.72K derived: sum of 2 quarters · filed 2025-03-14 | -$660.42K derived: sum of 3 quarters · filed 2025-03-14 | $130.88K 10-K · filed 2025-03-14 |
| 2023-09-30 | -$223.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$453.87K derived: sum of 2 quarters · filed 2024-11-08 | $337.43K 10-Q · filed 2024-11-08 | $337.43K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$230.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $560.61K 10-Q · filed 2024-08-07 | $560.61K derived: sum of 3 quarters · filed 2024-08-07 | $560.61K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $791.30K 10-Q · filed 2024-05-10 | $791.30K derived: sum of 2 quarters · filed 2024-05-10 | $791.30K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $15.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $15.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $15.00K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |